Rare diseases
Investigational molecules
Locations
Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis
SpainStudy of Nivolumab for Early Stage Hodgkin Lymphoma in Patients with Good Prognosis
SpainStudy on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors
SpainStudy of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors
SpainStudy on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients
SpainStudy on Reducing Oral Side Effects of Talquetamab in Multiple Myeloma Patients Using Pregabalin, Dexamethasone, and Clonazepam
SpainStudy on Ivermectin for Treating Strongyloidiasis in Adults with Normal Immune Function
SpainStudy on the Safety and Efficacy of Cevostamab with Lenalidomide or Iberdomide for Patients with High-Risk or Relapsed Multiple Myeloma
SpainStudy on Zanubrutinib and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients
SpainStudy Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
SpainStudy for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment
SpainStudy of Ciltacabtagene Autoleucel and Drug Combination for Treatment of High-Risk Smoldering Multiple Myeloma
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
